CERUTI, Maurizio

CERUTI, Maurizio  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 91 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autore(i) File
(E) and (Z)-29-methylidene-2,3-oxidosqualene as stereospecific mechanism-based inhibitors of 2,3-oxidosqualene cyclase. 1997 Ceruti M.; Rocco F.; Cattel L.
10 and 19-azasqualene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase from pig liver. 1995 Ceruti M.; Viola F.; Balliano G.; Rocco F.; Cattel L.
1H-NMR and 13C-NMR studies for the assignment of the structure of (6E)-10-azasqualene 2,3-epoxide and (6Z)-10-azasqualene 2,3-epoxide and their correlation with hypocholesterolemic and antifungal activity. 1991 Ceruti M.; Grosa G.; Rocco F.
2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 1994 Grosa G.; Ceruti M.; Dosio F.; Brusa P.; Cattel L.
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors 1991 Cattel L.; Ceruti M.; Balliano G.; Viola F.
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors. 1991 Cattel L.; Ceruti M.; Balliano G.; Viola F.
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 1996 Milla P.; Balliano G.; Ceruti M.; Cattel L.
2-Aza-2,3-dihydrosqualene and its N-oxide as inhibitors of sterol biosynthesis in bramble cell suspension cultures. 1985 Ceruti M.; Cattel L.; Schmitt P.; Benveniste P.
An NMR study of 2-aza and 19-azasqualene derivatives. Primo Congresso Congiunto Italiano-Svizzero di Chimica Farmaceutica, 1997 Pogliani L.; Ceruti M.; Viterbo D.
Antifungal and cytotoxic activiti of two inhibitors of 2,3-oxidosqualene cyclase 2005 Voyron S.; Forni P.; Rocco F.; Ceruti M.; Filipello Marchisio V.
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase. 2005 Voyron S.; Forni P.; Rocco F.; Ceruti M.; Filipello Marchisio V.
Antifungal spectrum of two acyclic inhibitors of 2,3-oxidosqualene cyclase. 1995 Airaudi D.; Ceruti M.; Bianco C.; Filipello Marchisio V.
Azasqualeni N-ossidi e bis-azasqualeni, inibitori dell'enzima squalene epossido ciclasi. 1985 Ceruti M.; Viola F.; Balliano G.; Cattel L.
Biocompatible micelles based on amphiphilic polyaspartamide-squalene derivatives as potential colloidal drug carriers. 2009 Ognibene M.C.; Rocco F.; Craparo E.F.; Picone P.; Ceruti M.; Giammona G.
Biopharmaceutical characterization of squalenoyl-cytarabine nanoparticles 2009 Rocco F.; Cosco D.; Vono M.; Paolino D.; Ceruti M.; Fresta M.
Calorimetric evidence of the interaction of a lipophilic conjugate of cytarabine with biomembrane models. 2009 Sarpietro M.G.; Micieli D.; Giuffrida M.C.; Rocco F.; Ceruti M.; Castelli F.
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. 2000 Cattel L.; Arpicco S.; Ceruti M.; Rocco F.; Dosio F.; Brusa P.
Comparison of experimental and molecular modelling results on phosphine oxides. 1989 Pogliani L.; Viterbo D.; Ceruti M.; Ugliengo P.
Comparison of NMR data with molecular dynamic calculations for squalenoyl-gemcitabine and derivatives 2012 Ceruti M.; Rocco F.; Di Pietro M.E.; De Luca G.; Tocci E.
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 1999 Milla P.; Balliano G.; Viola F.; Ceruti M.; Cattel L.; Poralla K.